A Phase I/Ii Study of Poziotinib Combined With Paclitaxel and Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer
Gastric Cancer - Germany
doi 10.1007/s10120-019-00958-4
Full Text
Open PDFAbstract
Available in full text
Date
April 3, 2019
Authors
Publisher
Springer Science and Business Media LLC